A Perspective of Decarbonization Pathways in Future Buildings in the United States

The commitment of electrification and decarbonization goals in the United States (U.S.) will significantly change the performance of future buildings. To meet these goals, it is critical to summarize the existing research related to building electrification and decarbonization and discuss future research pathways. This paper provides a perspective on decarbonization pathways of future buildings in the U.S. A critical review of the existing research was conducted, which is divided into three closely linked categories: technologies, economic impacts, and code regulations. Technologies support investments and code regulations while marketing affects the design of building codes and standards. In the meantime, code regulations guide the development of technologies and marketing. Based on the review, future potential research directions for building decarbonization are then discussed. Due to the needs of building decarbonization, future research will be multidisciplinary, conducted at a large geographic scale, and involve a multitude of metrics, which will undoubtedly introduce new challenges. The perspective presented in this paper will provide policy-makers, researchers, building owners, and other stakeholders with a way to understand the impact of electrification and decarbonization of future buildings in the U.S

KCNQ1 and type 2 diabetes: Study in Hubei Han Chinese and meta-analysis in East Asian populations

Recent genome-wide association studies in East Asian poulations reported the association of KCNQ1 variants with type 2 diabetes. In the present study, we first investigated the association between rs2237892 in KCNQ1 and type 2 diabetes in a Hubei Han Chinese population (223 type 2 diabetes patients and 201 controls). The frequencies of CC genotype and C allele in type 2 diabetes patients were significantly higher than those of controls group (CC: 51.6% vs 39.3%, P=0.001; C: 72.2% vs 61.2%, P=0.001). The odds ratio for the risk allele C was 1.65 (95%CI 1.23-2.2, P=0.001). Then, we systematically reviewed the association of SNPs (rs2237892, rs2237895, rs2237897, rs2074196) in KCNQ1 with type 2 diabetes risk in a meta-analysis. Significant heterogeneity between studies was found for SNPs rs2237892 and rs2237897. Combined odds ratios of the rs2237892 C, rs2237895 C, rs2237897 C, rs2074196 G allele were 1.35 (95% CI 1.29-1.41, P<0.0001), 1.27 (95%CI 1.23-1.32, P<0.0001), 1.32 (95%CI 1.21-1.43, P<0.0001), 1.30 (95%CI 1.25-1.35, P<0.0001) respectively. Our results and meta-analysis demonstrated that KCNQ1 polymorphisms were reproducibly associated with the risk of type 2 diabetes in Han Chinese and East Asian populations. © 2010 The Genetics Society of Korea and Springer Netherlands.link_to_subscribed_fulltex